Active Ingredient: RAMELTEON
Proprietary Name: RAMELTEON
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 8MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A213186
Product Number: 001
Approval Date: Aug 21, 2020
Applicant Holder Full Name: GRANULES PHARMACEUTICALS INC
Marketing Status:
Prescription
Patent and Exclusivity Information